G
2407
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Gaush Meditech Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -9% compared to the Hang Seng (Hong Kong)'s +8% growth.
Stocks Performance
2407 vs Hang Seng (Hong Kong)
Performance Gap
2407 vs Hang Seng (Hong Kong)
Performance By Year
2407 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Gaush Meditech Ltd
Glance View
Gaush Meditech Ltd. is an investment holding company, which engages in the provision of ophthalmic medical devices. The company is headquartered in Beijing, Beijing and currently employs 769 full-time employees. The company went IPO on 2022-12-12. The firm operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The firm's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
